{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T03:18:45Z","timestamp":1768533525814,"version":"3.49.0"},"reference-count":124,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"DOI":"10.1007\/s11926-025-01208-6","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T06:38:54Z","timestamp":1768199934000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Assessment of Disease Activity and Renal Prognosis in AAV \u2013 The Contribution of Urinary Biomarkers and Renal Biopsy"],"prefix":"10.1007","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4062-9412","authenticated-orcid":false,"given":"Juan Manuel","family":"Mej\u00eda-Vilet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4712-441X","authenticated-orcid":false,"given":"Marco A.","family":"Alba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4001-3995","authenticated-orcid":false,"given":"Andrea","family":"Hinojosa-Azaola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,12]]},"reference":[{"issue":"8","key":"1208_CR1","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nrrheum.2014.103","volume":"10","author":"JC Jennette","year":"2014","unstructured":"Jennette JC, Falk RJ. Pathogenesis of antineutrophil cytoplasmic autoantibody-mediated disease. Nat Rev Rheumatol. 2014;10(8):463\u201373. https:\/\/doi.org\/10.1038\/nrrheum.2014.103.","journal-title":"Nat Rev Rheumatol"},{"issue":"4","key":"1208_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102495","volume":"19","author":"A Kronbichler","year":"2020","unstructured":"Kronbichler A, Shin JI, Lee KH, Nakagomi D, Quintana LF, Busch M, et al. Clinical associations of renal involvement in ANCA-associated vasculitis. Autoimmun Rev. 2020;19(4):102495. https:\/\/doi.org\/10.1016\/j.autrev.2020.102495.","journal-title":"Autoimmun Rev"},{"issue":"11","key":"1208_CR3","doi-asserted-by":"publisher","first-page":"e762","DOI":"10.1016\/S2665-9913(24)00187-5","volume":"6","author":"K Gisslander","year":"2024","unstructured":"Gisslander K, White A, Aslett L, Hruskova Z, Lamprecht P, Musial J, et al. Data-driven subclassification of ANCA-associated vasculitis: model-based clustering of a federated international cohort. Lancet Rheumatol. 2024;6(11):e762\u201370. https:\/\/doi.org\/10.1016\/S2665-9913(24)00187-5.","journal-title":"Lancet Rheumatol."},{"key":"1208_CR4","doi-asserted-by":"crossref","unstructured":"4. Ivkovic V, Windpessl M, Berke I, Geetha D, Callemeyn J, Norouzi S, et al. ANCA-associated glomerulonephritis: Diagnosis and therapy proceedings of the Henry Shavelle Lectureship. Glomerular Dis. 2025;5(1):26\u201347. 10.1159\/000542925.","DOI":"10.1159\/000542925"},{"key":"1208_CR5","unstructured":"5. Jennette J, Thomas D. In: Jennette J, Olson J, Silva F, D\u00c1gati V, editors. Heptinstall\u2019s Pathology of the Kidney 7th Ed, Philadelphia: Lippincott Williams & Wilkins; 2015. p. 686\u2013713."},{"key":"1208_CR6","doi-asserted-by":"crossref","unstructured":"6. Rhee RL, Hogan SL, Poulton CJ, McGregor JA, Landis JR, Falk RJ, et al. Trends in long-term outcomes among patients with antineutrophil cytoplasmic antibody-associated vasculitis with renal disease. Arthritis Rheumatol. 2016;68(7):1711-20. 10.1002\/art.39614.","DOI":"10.1002\/art.39614"},{"issue":"1","key":"1208_CR7","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1136\/annrheumdis-2013-203927","volume":"74","author":"J Robson","year":"2015","unstructured":"Robson J, Doll H, Suppiah R, Flossmann O, Harper L, Hoglund P, et al. Damage in the anca-associated vasculitides: long-term data from the European vasculitis study group (EUVAS) therapeutic trials. Ann Rheum Dis. 2015;74(1):177\u201384. https:\/\/doi.org\/10.1136\/annrheumdis-2013-203927.","journal-title":"Ann Rheum Dis"},{"key":"1208_CR8","doi-asserted-by":"crossref","unstructured":"8. Sachez-Alamo B, Moi L, Bajema I, Berden A, Flossmann O, Hruskova Z, et al. Long-term outcome of kidney function in patients with ANCA-associated vasculitis. Nephrol Dial Transplant. 2024;39(9):1483-93. 10.1093\/ndt\/gfae018.","DOI":"10.1093\/ndt\/gfae018"},{"key":"1208_CR9","doi-asserted-by":"crossref","unstructured":"9. Berti A, Cornec-Le Gall E, Cornec D, Casal Moura M, Matteson EL, Crowson CS, et al. Incidence, prevalence, mortality and chronic renal damage of anti-neutrophil cytoplasmic antibody-associated glomerulonephritis in a 20-year population-based cohort. Nephrol Dial Transplant. 2019;34(9):1508-17. 10.1093\/ndt\/gfy250.","DOI":"10.1093\/ndt\/gfy250"},{"key":"1208_CR10","doi-asserted-by":"crossref","unstructured":"10. Kidney Disease: Improving Global Outcomes AVWG. KDIGO 2024 Clinical Practice Guideline for the management of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis. Kidney Int. 2024;105(3S):S71-S116. 10.1016\/j.kint.2023.10.008.","DOI":"10.1016\/j.kint.2023.10.008"},{"issue":"5","key":"1208_CR11","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1007\/s10157-012-0701-8","volume":"17","author":"F Ferrario","year":"2013","unstructured":"Ferrario F, Vanzati A, Pagni F. Pathology of ANCA-associated vasculitis. Clin Exp Nephrol. 2013;17(5):652\u20138. https:\/\/doi.org\/10.1007\/s10157-012-0701-8.","journal-title":"Clin Exp Nephrol"},{"issue":"3","key":"1208_CR12","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1681\/ASN.V103499","volume":"10","author":"MA Cunningham","year":"1999","unstructured":"Cunningham MA, Huang XR, Dowling JP, Tipping PG, Holdsworth SR. Prominence of cell-mediated immunity effectors in \u201cpauci-immune\u201d glomerulonephritis. J Am Soc Nephrol. 1999;10(3):499\u2013506. https:\/\/doi.org\/10.1681\/ASN.V103499.","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"1208_CR13","doi-asserted-by":"publisher","first-page":"3651","DOI":"10.1002\/art.20607","volume":"50","author":"S Weidner","year":"2004","unstructured":"Weidner S, Carl M, Riess R, Rupprecht HD. Histologic analysis of renal leukocyte infiltration in antineutrophil cytoplasmic antibody-associated vasculitis: importance of monocyte and neutrophil infiltration in tissue damage. Arthritis Rheum. 2004;50(11):3651\u20137. https:\/\/doi.org\/10.1002\/art.20607.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"1208_CR14","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1053\/j.semdp.2009.08.001","volume":"26","author":"R John","year":"2009","unstructured":"John R, Herzenberg AM. Vasculitis affecting the kidney. Semin Diagn Pathol. 2009;26(2):89\u2013102. https:\/\/doi.org\/10.1053\/j.semdp.2009.08.001.","journal-title":"Semin Diagn Pathol"},{"issue":"6","key":"1208_CR15","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1093\/ndt\/16.suppl_6.80","volume":"16","author":"JC Jennette","year":"2001","unstructured":"Jennette JC, Thomas DB. Crescentic glomerulonephritis. Nephrol Dial Transplant. 2001;16(6):80\u20132. https:\/\/doi.org\/10.1093\/ndt\/16.suppl_6.80.","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"1208_CR16","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1053\/ajkd.2003.50142","volume":"41","author":"A Vizjak","year":"2003","unstructured":"Vizjak A, Rott T, Koselj-Kajtna M, Rozman B, Kaplan-Pavlovcic S, Ferluga D. Histologic and immunohistologic study and clinical presentation of ANCA-associated glomerulonephritis with correlation to ANCA antigen specificity. Am J Kidney Dis. 2003;41(3):539\u201349. https:\/\/doi.org\/10.1053\/ajkd.2003.50142.","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"1208_CR17","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1053\/ajkd.2000.8969","volume":"36","author":"HA Hauer","year":"2000","unstructured":"Hauer HA, Bajema IM, de Heer E, Hermans J, Hagen EC, Bruijn JA. Distribution of renal lesions in idiopathic systemic vasculitis: a three-dimensional analysis of 87 glomeruli. Am J Kidney Dis. 2000;36(2):257\u201365. https:\/\/doi.org\/10.1053\/ajkd.2000.8969.","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"1208_CR18","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.berh.2018.10.010","volume":"32","author":"AE Berden","year":"2018","unstructured":"Berden AE, Wester Trejo MAC, Bajema IM. Investigations in systemic vasculitis - the role of renal pathology. Best Pract Res Clin Rheumatol. 2018;32(1):83\u201393. https:\/\/doi.org\/10.1016\/j.berh.2018.10.010.","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"1","key":"1208_CR19","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1046\/j.1523-1755.2002.00089.x","volume":"61","author":"HA Hauer","year":"2002","unstructured":"Hauer HA, Bajema IM, van Houwelingen HC, Ferrario F, Noel LH, Waldherr R, et al. Renal histology in ANCA-associated vasculitis: differences between diagnostic and serologic subgroups. Kidney Int. 2002;61(1):80\u20139. https:\/\/doi.org\/10.1046\/j.1523-1755.2002.00089.x.","journal-title":"Kidney Int."},{"issue":"6","key":"1208_CR20","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/s0046-8177(83)80007-0","volume":"14","author":"T Watanabe","year":"1983","unstructured":"Watanabe T, Nagafuchi Y, Yoshikawa Y, Toyoshima H. Renal papillary necrosis associated with Wegener\u2019s granulomatosis. Hum Pathol. 1983;14(6):551\u20137. https:\/\/doi.org\/10.1016\/s0046-8177(83)80007-0.","journal-title":"Hum Pathol"},{"issue":"10","key":"1208_CR21","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.2215\/CJN.02500317","volume":"12","author":"JC Jennette","year":"2017","unstructured":"Jennette JC, Nachman PH. ANCA glomerulonephritis and vasculitis. Clin J Am Soc Nephrol. 2017;12(10):1680\u201391. https:\/\/doi.org\/10.2215\/CJN.02500317.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"1208_CR22","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S0002-9440(10)62951-3","volume":"167","author":"H Xiao","year":"2005","unstructured":"Xiao H, Heeringa P, Liu Z, Huugen D, Hu P, Maeda N, et al. The role of neutrophils in the induction of glomerulonephritis by anti-myeloperoxidase antibodies. Am J Pathol. 2005;167(1):39\u201345. https:\/\/doi.org\/10.1016\/S0002-9440(10)62951-3.","journal-title":"Am J Pathol"},{"key":"1208_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00256","volume":"7","author":"D Soderberg","year":"2016","unstructured":"Soderberg D, Segelmark M. Neutrophil extracellular traps in ANCA-associated vasculitis. Front Immunol. 2016;7:256. https:\/\/doi.org\/10.3389\/fimmu.2016.00256.","journal-title":"Front Immunol"},{"key":"1208_CR24","doi-asserted-by":"crossref","unstructured":"24. Brouwer E, Huitema MG, Mulder AH, Heeringa P, van Goor H, Tervaert JW, et al. Neutrophil activation in vitro and in vivo in Wegener\u2019s granulomatosis. Kidney Int. 1994;45(4):1120-31. 10.1038\/ki.1994.149.","DOI":"10.1038\/ki.1994.149"},{"issue":"3","key":"1208_CR25","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1046\/j.1523-1755.1999.055003852.x","volume":"55","author":"P Cockwell","year":"1999","unstructured":"Cockwell P, Brooks CJ, Adu D, Savage CO. Interleukin-8: a pathogenetic role in antineutrophil cytoplasmic autoantibody-associated glomerulonephritis. Kidney Int. 1999;55(3):852\u201363. https:\/\/doi.org\/10.1046\/j.1523-1755.1999.055003852.x.","journal-title":"Kidney Int"},{"issue":"11","key":"1208_CR26","doi-asserted-by":"publisher","first-page":"4115","DOI":"10.1073\/pnas.87.11.4115","volume":"87","author":"RJ Falk","year":"1990","unstructured":"Falk RJ, Terrell RS, Charles LA, Jennette JC. Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci U S A. 1990;87(11):4115\u20139. https:\/\/doi.org\/10.1073\/pnas.87.11.4115.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"1208_CR27","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/nm.1959","volume":"15","author":"K Kessenbrock","year":"2009","unstructured":"Kessenbrock K, Krumbholz M, Schonermarck U, Back W, Gross WL, Werb Z, et al. Netting neutrophils in autoimmune small-vessel vasculitis. Nat Med. 2009;15(6):623\u20135. https:\/\/doi.org\/10.1038\/nm.1959.","journal-title":"Nat Med"},{"issue":"2","key":"1208_CR28","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/ki.1992.52","volume":"41","author":"BH Ewert","year":"1992","unstructured":"Ewert BH, Jennette JC, Falk RJ. Anti-myeloperoxidase antibodies stimulate neutrophils to damage human endothelial cells. Kidney Int. 1992;41(2):375\u201383. https:\/\/doi.org\/10.1038\/ki.1992.52.","journal-title":"Kidney Int"},{"key":"1208_CR29","doi-asserted-by":"crossref","unstructured":"29. Radford DJ, Luu NT, Hewins P, Nash GB, Savage CO. Antineutrophil cytoplasmic antibodies stabilize adhesion and promote migration of flowing neutrophils on endothelial cells. Arthritis Rheum. 2001;44(12):2851-61. 10.1002\/1529-0131(200112)44:12<2851::aid-art473>3.0.co;2-2.","DOI":"10.1002\/1529-0131(200112)44:12<2851::AID-ART473>3.0.CO;2-2"},{"key":"1208_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.imlet.2024.106933","volume":"270","author":"M Prendecki","year":"2024","unstructured":"Prendecki M, Gurung A, Pisacano N, Pusey CD. The role of neutrophils in ANCA-associated vasculitis. Immunol Lett. 2024;270:106933. https:\/\/doi.org\/10.1016\/j.imlet.2024.106933.","journal-title":"Immunol Lett"},{"issue":"5","key":"1208_CR31","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1165\/ajrcmb.13.5.7576688","volume":"13","author":"DM Brown","year":"1995","unstructured":"Brown DM, Drost E, Donaldson K, MacNee W. Deformability and CD11\/CD18 expression of sequestered neutrophils in normal and inflamed lungs. Am J Respir Cell Mol Biol. 1995;13(5):531\u20139. https:\/\/doi.org\/10.1165\/ajrcmb.13.5.7576688.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"1","key":"1208_CR32","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1111\/j.1523-1755.2005.00063.x","volume":"67","author":"WY Tse","year":"2005","unstructured":"Tse WY, Nash GB, Hewins P, Savage CO, Adu D. ANCA-induced neutrophil F-actin polymerization: implications for microvascular inflammation. Kidney Int. 2005;67(1):130\u20139. https:\/\/doi.org\/10.1111\/j.1523-1755.2005.00063.x.","journal-title":"Kidney Int"},{"issue":"1","key":"1208_CR33","doi-asserted-by":"publisher","first-page":"4","DOI":"10.2215\/CJN.11501114","volume":"10","author":"JC Jennette","year":"2015","unstructured":"Jennette JC, Falk RJ. ANCAs are also antimonocyte cytoplasmic autoantibodies. Clin J Am Soc Nephrol. 2015;10(1):4\u20136. https:\/\/doi.org\/10.2215\/CJN.11501114.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"1208_CR34","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1046\/j.1523-1755.2001.00019.x","volume":"60","author":"IM Bajema","year":"2001","unstructured":"Bajema IM, Hagen EC, de Heer E, van der Woude FJ, Bruijn JA. Colocalization of ANCA-antigens and fibrinoid necrosis in ANCA-associated vasculitis. Kidney Int. 2001;60(5):2025\u201330. https:\/\/doi.org\/10.1046\/j.1523-1755.2001.00019.x.","journal-title":"Kidney Int"},{"issue":"1","key":"1208_CR35","first-page":"149","volume":"32","author":"T Imamoto","year":"2014","unstructured":"Imamoto T, Nakazawa D, Shida H, Suzuki A, Otsuka N, Tomaru U, et al. Possible linkage between microscopic polyangiitis and thrombosis via neutrophil extracellular traps. Clin Exp Rheumatol. 2014;32(1):149\u201350.","journal-title":"Clin Exp Rheumatol."},{"key":"1208_CR36","unstructured":"36. Abreu-Velez AM, Smith JG, Jr., Howard MS. Presence of neutrophil extracellular traps and antineutrophil cytoplasmic antibodies associated with vasculitides. N Am J Med Sci. 2009;1(6):309\u2009\u2212\u200913."},{"issue":"5663","key":"1208_CR37","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1126\/science.1092385","volume":"303","author":"V Brinkmann","year":"2004","unstructured":"Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, Weiss DS, et al. Neutrophil extracellular traps kill bacteria. Science. 2004;303(5663):1532\u20135. https:\/\/doi.org\/10.1126\/science.1092385.","journal-title":"Science"},{"issue":"7","key":"1208_CR38","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1038\/sj.ki.5002371","volume":"72","author":"DA Alcorta","year":"2007","unstructured":"Alcorta DA, Barnes DA, Dooley MA, Sullivan P, Jonas B, Liu Y, et al. Leukocyte gene expression signatures in antineutrophil cytoplasmic autoantibody and lupus glomerulonephritis. Kidney Int. 2007;72(7):853\u201364. https:\/\/doi.org\/10.1038\/sj.ki.5002371.","journal-title":"Kidney Int"},{"key":"1208_CR39","doi-asserted-by":"crossref","unstructured":"39. Xiao H, Heeringa P, Hu P, Liu Z, Zhao M, Aratani Y, et al. Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. J Clin Invest. 2002;110(7):955\u2009\u2212\u200963. 10.1172\/JCI15918.","DOI":"10.1172\/JCI0215918"},{"issue":"2","key":"1208_CR40","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1681\/ASN.2013020143","volume":"25","author":"H Xiao","year":"2014","unstructured":"Xiao H, Dairaghi DJ, Powers JP, Ertl LS, Baumgart T, Wang Y, et al. C5a receptor (CD88) blockade protects against MPO-ANCA GN. J Am Soc Nephrol. 2014;25(2):225\u201331. https:\/\/doi.org\/10.1681\/ASN.2013020143.","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"1208_CR41","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.kint.2024.08.022","volume":"106","author":"P Hu","year":"2024","unstructured":"Hu P, Xiao H, Alba MA, Atkins HM, Gou S, Hu Y, et al. Myeloperoxidase-ANCA IgG induces different forms of small vessel vasculitis based on type of synergistic immune stimuli. Kidney Int. 2024;106(5):870\u201386. https:\/\/doi.org\/10.1016\/j.kint.2024.08.022.","journal-title":"Kidney Int"},{"issue":"3","key":"1208_CR42","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1046\/j.1523-1755.2003.00843.x","volume":"63","author":"JC Jennette","year":"2003","unstructured":"Jennette JC. Rapidly progressive crescentic glomerulonephritis. Kidney Int. 2003;63(3):1164\u201377. https:\/\/doi.org\/10.1046\/j.1523-1755.2003.00843.x.","journal-title":"Kidney Int"},{"issue":"4","key":"1208_CR43","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1097\/PAP.0000000000000154","volume":"24","author":"T Al-Hussain","year":"2017","unstructured":"Al-Hussain T, Hussein MH, Conca W, Al Mana H, Akhtar M. Pathophysiology of ANCA-associated vasculitis. Adv Anat Pathol. 2017;24(4):226\u201334. https:\/\/doi.org\/10.1097\/PAP.0000000000000154.","journal-title":"Adv Anat Pathol"},{"key":"1208_CR44","unstructured":"44. Bosch X, Mirapeix E, Font J, Borrellas X, Rodriguez R, Lopez-Soto A, et al. Prognostic implication of anti-neutrophil cytoplasmic autoantibodies with myeloperoxidase specificity in anti-glomerular basement membrane disease. Clin Nephrol. 1991;36(3):107\u2009\u2212\u200913."},{"issue":"10","key":"1208_CR45","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/s0046-8177(84)80124-0","volume":"15","author":"MA Weiss","year":"1984","unstructured":"Weiss MA, Crissman JD. Renal biopsy findings in Wegener\u2019s granulomatosis: segmental necrotizing glomerulonephritis with glomerular thrombosis. Hum Pathol. 1984;15(10):943\u201356. https:\/\/doi.org\/10.1016\/s0046-8177(84)80124-0.","journal-title":"Hum Pathol"},{"key":"1208_CR46","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1159\/000314776","volume":"169","author":"JC Jennette","year":"2011","unstructured":"Jennette JC, Xiao H, Falk R, Gasim AM. Experimental models of vasculitis and glomerulonephritis induced by antineutrophil cytoplasmic autoantibodies. Contrib Nephrol. 2011;169:211\u201320. https:\/\/doi.org\/10.1159\/000314776.","journal-title":"Contrib Nephrol"},{"issue":"657","key":"1208_CR47","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abg3277","volume":"14","author":"ME Melica","year":"2022","unstructured":"Melica ME, Antonelli G, Semeraro R, Angelotti ML, Lugli G, Landini S, et al. Differentiation of crescent-forming kidney progenitor cells into podocytes attenuates severe glomerulonephritis in mice. Sci Transl Med. 2022;14(657):eabg3277. https:\/\/doi.org\/10.1126\/scitranslmed.abg3277.","journal-title":"Sci Transl Med"},{"issue":"3","key":"1208_CR48","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1097\/00041552-199905000-00002","volume":"8","author":"PG Tipping","year":"1999","unstructured":"Tipping PG, Kitching AR, Cunningham MA, Holdsworth SR. Immunopathogenesis of crescentic glomerulonephritis. Curr Opin Nephrol Hypertens. 1999;8(3):281\u20136. https:\/\/doi.org\/10.1097\/00041552-199905000-00002.","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"2","key":"1208_CR49","first-page":"120","volume":"98","author":"AR Rich","year":"1956","unstructured":"Rich AR. The pathology and pathogenesis of experimental anaphylactic glomerulonephritis in relation to human acute glomerulonephritis. Bull Johns Hopkins Hosp. 1956;98(2):120\u201351.","journal-title":"Bull Johns Hopkins Hosp"},{"issue":"4","key":"1208_CR50","first-page":"653","volume":"45","author":"P Vassalli","year":"1964","unstructured":"Vassalli P, McCluskey RT. The pathogenic role of the coagulation process in rabbit Masugi nephritis. Am J Pathol. 1964;45(4):653\u201377.","journal-title":"Am J Pathol"},{"issue":"5","key":"1208_CR51","first-page":"495","volume":"126","author":"BL Casselman","year":"1995","unstructured":"Casselman BL, Kilgore KS, Miller BF, Warren JS. Antibodies to neutrophil cytoplasmic antigens induce monocyte chemoattractant protein-1 secretion from human monocytes. J Lab Clin Med. 1995;126(5):495\u2013502.","journal-title":"J Lab Clin Med"},{"issue":"6","key":"1208_CR52","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1172\/JCI119662","volume":"100","author":"DR Ralston","year":"1997","unstructured":"Ralston DR, Marsh CB, Lowe MP, Wewers MD. Antineutrophil cytoplasmic antibodies induce monocyte IL-8 release. Role of surface proteinase-3, alpha1-antitrypsin, and Fcgamma receptors. J Clin Invest. 1997;100(6):1416\u201324. https:\/\/doi.org\/10.1172\/JCI119662.","journal-title":"J Clin Invest"},{"issue":"11","key":"1208_CR53","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1681\/ASN.V7112271","volume":"7","author":"RC Atkins","year":"1996","unstructured":"Atkins RC, Nikolic-Paterson DJ, Song Q, Lan HY. Modulators of crescentic glomerulonephritis. J Am Soc Nephrol. 1996;7(11):2271\u20138. https:\/\/doi.org\/10.1681\/ASN.V7112271.","journal-title":"J Am Soc Nephrol"},{"issue":"10","key":"1208_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2021.102911","volume":"20","author":"Y Vegting","year":"2021","unstructured":"Vegting Y, Vogt L, Anders HJ, de Winther MPJ, Bemelman FJ, Hilhorst ML. Monocytes and macrophages in ANCA-associated vasculitis. Autoimmun Rev. 2021;20(10):102911. https:\/\/doi.org\/10.1016\/j.autrev.2021.102911.","journal-title":"Autoimmun Rev"},{"issue":"3","key":"1208_CR55","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1097\/MNH.0000000000000596","volume":"29","author":"L Anguiano","year":"2020","unstructured":"Anguiano L, Kain R, Anders HJ. The glomerular crescent: triggers, evolution, resolution, and implications for therapy. Curr Opin Nephrol Hypertens. 2020;29(3):302\u20139. https:\/\/doi.org\/10.1097\/MNH.0000000000000596.","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"6","key":"1208_CR56","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/j.kint.2018.08.035","volume":"94","author":"D Nakazawa","year":"2018","unstructured":"Nakazawa D, Marschner JA, Platen L, Anders HJ. Extracellular traps in kidney disease. Kidney Int. 2018;94(6):1087\u201398. https:\/\/doi.org\/10.1016\/j.kint.2018.08.035.","journal-title":"Kidney Int"},{"issue":"11","key":"1208_CR57","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.1681\/ASN.V11112036","volume":"11","author":"MP Rastaldi","year":"2000","unstructured":"Rastaldi MP, Ferrario F, Crippa A, Dell\u2019antonio G, Casartelli D, Grillo C, et al. Glomerular monocyte-macrophage features in ANCA-positive renal vasculitis and cryoglobulinemic nephritis. J Am Soc Nephrol. 2000;11(11):2036\u201343. https:\/\/doi.org\/10.1681\/ASN.V11112036.","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"1208_CR58","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1002\/path.4046","volume":"228","author":"M Ryu","year":"2012","unstructured":"Ryu M, Migliorini A, Miosge N, Gross O, Shankland S, Brinkkoetter PT, et al. Plasma leakage through glomerular basement membrane ruptures triggers the proliferation of parietal epithelial cells and crescent formation in non-inflammatory glomerular injury. J Pathol. 2012;228(4):482\u201394. https:\/\/doi.org\/10.1002\/path.4046.","journal-title":"J Pathol"},{"issue":"3","key":"1208_CR59","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1097\/MNH.0b013e32834583ec","volume":"20","author":"SK Singh","year":"2011","unstructured":"Singh SK, Jeansson M, Quaggin SE. New insights into the pathogenesis of cellular crescents. Curr Opin Nephrol Hypertens. 2011;20(3):258\u201362. https:\/\/doi.org\/10.1097\/MNH.0b013e32834583ec.","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"2","key":"1208_CR60","first-page":"105","volume":"12","author":"FJ der Van Woude","year":"1999","unstructured":"der Van Woude FJ, Ferrario F. Renal involvement in ANCA-associated systemic vasculitis. J Nephrol. 1999;12(2):105\u201328.","journal-title":"J Nephrol"},{"issue":"4","key":"1208_CR61","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1159\/000442323","volume":"1","author":"H Xiao","year":"2016","unstructured":"Xiao H, Hu P, Falk RJ, Jennette JC. Overview of the pathogenesis of ANCA-associated vasculitis. Kidney Dis (Basel). 2016;1(4):205\u201315. https:\/\/doi.org\/10.1159\/000442323.","journal-title":"Kidney Dis (Basel)"},{"key":"1208_CR62","doi-asserted-by":"publisher","DOI":"10.1177\/1759720X221125979","volume":"14","author":"M Casal Moura","year":"2022","unstructured":"Casal Moura M, Branco C, Martins-Martinho J, Ferraro JL, Berti A, Nogueira E, et al. A glance into the future of anti-neutrophil cytoplasmic antibody-associated vasculitis. Ther Adv Musculoskelet Dis. 2022;14:1759720X221125979. https:\/\/doi.org\/10.1177\/1759720X221125979.","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"2","key":"1208_CR63","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1002\/acr.22414","volume":"67","author":"N Milman","year":"2015","unstructured":"Milman N, Boonen A, Merkel PA, Tugwell P. Mapping of the outcome measures in rheumatology core set for antineutrophil cytoplasmic antibody-associated vasculitis to the International Classification of Function, Disability and Health. Arthritis Care Res (Hoboken). 2015;67(2):255\u201363. https:\/\/doi.org\/10.1002\/acr.22414.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"1208_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-025-01306-w","author":"M Casal Moura","year":"2025","unstructured":"Casal Moura M, Merkel PA, Jayne D, Cid MC, Basu N, Hellmich B, et al. Challenges in the diagnosis, classification and prognosis of ANCA-associated vasculitis. Nat Rev Rheumatol. 2025. https:\/\/doi.org\/10.1038\/s41584-025-01306-w.","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"1208_CR65","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1136\/ard-2022-223764","volume":"83","author":"B Hellmich","year":"2024","unstructured":"Hellmich B, Sanchez-Alamo B, Schirmer JH, Berti A, Blockmans D, Cid MC, et al. EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update. Ann Rheum Dis. 2024;83(1):30\u201347. https:\/\/doi.org\/10.1136\/ard-2022-223764.","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"1208_CR66","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1007\/s10067-025-07412-0","volume":"44","author":"LY Xie","year":"2025","unstructured":"Xie LY, Qiu XY, Li YN, Zhang HM, Chen HS, Gu QH, et al. Serum ferritin is a superior biomarker for evaluating disease activity and kidney injury compared with C-reactive protein in anti-neutrophil cytoplasmic antibody-associated vasculitis. Clin Rheumatol. 2025;44(5):2009\u201321. https:\/\/doi.org\/10.1007\/s10067-025-07412-0.","journal-title":"Clin Rheumatol"},{"issue":"7","key":"1208_CR67","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.3899\/jrheum.131038","volume":"41","author":"AJ Mohammad","year":"2014","unstructured":"Mohammad AJ, Segelmark M. A population-based study showing better renal prognosis for proteinase 3 antineutrophil cytoplasmic antibody (ANCA)-associated nephritis versus myeloperoxidase ANCA-associated nephritis. J Rheumatol. 2014;41(7):1366\u201373. https:\/\/doi.org\/10.3899\/jrheum.131038.","journal-title":"J Rheumatol"},{"issue":"4","key":"1208_CR68","doi-asserted-by":"publisher","first-page":"887","DOI":"10.55563\/clinexprheumatol\/jui6xj","volume":"42","author":"W Rah","year":"2024","unstructured":"Rah W, Song JJ, Park YB, Lee SW. First-year cumulative myeloperoxidase-ANCA titres are associated with all-cause mortality in patients with microscopic polyangiitis. Clin Exp Rheumatol. 2024;42(4):887\u201394. https:\/\/doi.org\/10.55563\/clinexprheumatol\/jui6xj.","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"1208_CR69","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/cei.13530","volume":"203","author":"J Oristrell","year":"2021","unstructured":"Oristrell J, Loureiro-Amigo J, Solans R, Valenzuela MP, Mons\u00e1lvez V, Segarra A, et al. Relapse rate and renal prognosis in ANCA-associated vasculitis according to long-term ANCA patterns. Clin Exp Immunol. 2021;203(2):209\u201318. https:\/\/doi.org\/10.1111\/cei.13530.","journal-title":"Clin Exp Immunol."},{"key":"1208_CR70","doi-asserted-by":"crossref","unstructured":"70. Jiang C, Liu J, Wang H, Liu H, Fu Z, Li M, et al. Anti-neutrophil cytoplasmic antibody patterns can predict clinical relapse in ANCA-associated vasculitis: overall population and subgroups. Clin Exp Rheumatol. 2023;41(4):848\u2009\u2212\u200955. 10.55563\/clinexprheumatol\/087jdd.","DOI":"10.55563\/clinexprheumatol\/087jdd"},{"key":"1208_CR71","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1214945","volume":"14","author":"I Wojcik","year":"2023","unstructured":"Wojcik I, Wuhrer M, Heeringa P, Stegeman CA, Rutgers A, Falck D. Specific IgG glycosylation differences precede relapse in PR3-ANCA associated vasculitis patients with and without ANCA rise. Front Immunol. 2023;14:1214945. https:\/\/doi.org\/10.3389\/fimmu.2023.1214945.","journal-title":"Front Immunol"},{"key":"1208_CR72","doi-asserted-by":"crossref","unstructured":"72. Wacrenier S, Riou J, Jourdain P, Guibert F, Henry N, Djema A, et al. Lymphopaenia at diagnosis of anti-neutrophil cytoplasmic antibody-vasculitis with renal involvement is correlated with severity and renal prognosis. Nephrol Dial Transplant. 2022;37(6):1078-87. 10.1093\/ndt\/gfab158.","DOI":"10.1093\/ndt\/gfab158"},{"key":"1208_CR73","doi-asserted-by":"crossref","unstructured":"73. Li W, Hao W, Gao C, Cao W, Liu R, Dong F, et al. Characteristics and clustering analysis of peripheral-blood lymphocyte subsets in patients with ANCA-associated vasculitis. Clin Exp Rheumatol. 2025;43(4):702-9. 10.55563\/clinexprheumatol\/2a7422.","DOI":"10.55563\/clinexprheumatol\/2a7422"},{"issue":"1","key":"1208_CR74","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-025-03552-5","volume":"27","author":"W Hao","year":"2025","unstructured":"Hao W, Liu Q, Li X, Xu Y, Guan W, Zhang L, et al. CCL23 is a potential biomarker for antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Res Ther. 2025;27(1):83. https:\/\/doi.org\/10.1186\/s13075-025-03552-5.","journal-title":"Arthritis Res Ther"},{"key":"1208_CR75","doi-asserted-by":"crossref","unstructured":"75. Treppo E, Monti S, Delvino P, Marvisi C, Ricordi C, La Rocca G, et al. Systemic vasculitis: one year in review 2024. Clin Exp Rheumatol. 2024;42(4):771\u2009\u2212\u200981. 10.55563\/clinexprheumatol\/gkve60.","DOI":"10.55563\/clinexprheumatol\/gkve60"},{"issue":"19","key":"1208_CR76","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241914436","volume":"24","author":"S Matsuda","year":"2023","unstructured":"Matsuda S, Oe K, Kotani T, Okazaki A, Kiboshi T, Suzuka T, et al. Serum complement C4 levels are a useful biomarker for predicting end-stage renal disease in Microscopic Polyangiitis. Int J Mol Sci. 2023;24(19):14436. https:\/\/doi.org\/10.3390\/ijms241914436.","journal-title":"Int J Mol Sci"},{"issue":"11","key":"1208_CR77","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.2215\/CJN.03190321","volume":"16","author":"M Kauffmann","year":"2021","unstructured":"Kauffmann M, Bobot M, Robert T, Burtey S, Couvrat-Desvergnes G, Lavainne F, et al. Disease activity and adverse events in patients with ANCA-associated vasculitides undergoing long-term dialysis. Clin J Am Soc Nephrol. 2021;16(11):1665\u201375. https:\/\/doi.org\/10.2215\/CJN.03190321.","journal-title":"Clin J Am Soc Nephrol"},{"key":"1208_CR78","doi-asserted-by":"publisher","first-page":"11881","DOI":"10.2147\/JIR.S494848","volume":"17","author":"A Ni","year":"2024","unstructured":"Ni A, Xu Y, Chen J, Han F. Advances in the assessment and treatment of anti-neutrophil cytoplasmic antibody-associated glomerulonephritis. J Inflamm Res. 2024;17:11881\u2013900. https:\/\/doi.org\/10.2147\/JIR.S494848.","journal-title":"J Inflamm Res"},{"key":"1208_CR79","doi-asserted-by":"crossref","unstructured":"79. de Lind van Wijngaarden RA, Hauer HA, Wolterbeek R, Jayne DR, Gaskin G, Rasmussen N, et al; EUVAS. Chances of renal recovery for dialysis-dependent ANCA-associated glomerulonephritis. J Am Soc Nephrol. 2007;18(7):2189-97. 10.1681\/ASN.2007010066.","DOI":"10.1681\/ASN.2007010066"},{"issue":"5","key":"1208_CR80","doi-asserted-by":"publisher","first-page":"905","DOI":"10.2215\/CJN.08290813","volume":"9","author":"T Lee","year":"2014","unstructured":"Lee T, Gasim A, Derebail VK, Chung Y, McGregor JG, Lionaki S, et al. Predictors of treatment outcomes in ANCA-associated vasculitis with severe kidney failure. Clin J Am Soc Nephrol. 2014;9(5):905\u201313. https:\/\/doi.org\/10.2215\/CJN.08290813.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"1208_CR81","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1093\/rheumatology\/key260","volume":"58","author":"MAC Wester Trejo","year":"2019","unstructured":"Wester Trejo MAC, Flo\u00dfmann O, Westman KW, H\u00f6glund P, Hagen EC, Walsh M, et al. Renal relapse in antineutrophil cytoplasmic autoantibody-associated vasculitis: unpredictable, but predictive of renal outcome. Rheumatology (Oxford). 2019;58(1):103\u20139. https:\/\/doi.org\/10.1093\/rheumatology\/key260.","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"1208_CR82","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1007\/s10067-020-04936-5","volume":"39","author":"JM Mej\u00eda-Vilet","year":"2020","unstructured":"Mej\u00eda-Vilet JM, Mart\u00edn-Nares E, Cano-Verduzco ML, P\u00e9rez-Arias AA, Sedano-Montoya MA, Hinojosa-Azaola A. Validation of a renal risk score in a cohort of ANCA-associated vasculitis patients with severe kidney damage. Clin Rheumatol. 2020;39(6):1935\u201343. https:\/\/doi.org\/10.1007\/s10067-020-04936-5.","journal-title":"Clin Rheumatol"},{"issue":"1","key":"1208_CR83","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1093\/ndt\/gfh563","volume":"20","author":"I Neumann","year":"2005","unstructured":"Neumann I, Kain R, Regele H, Soleiman A, Kandutsch S, Meisl FT. Histological and clinical predictors of early and late renal outcome in ANCA-associated vasculitis. Nephrol Dial Transplant. 2005;20(1):96\u2013104. https:\/\/doi.org\/10.1093\/ndt\/gfh563.","journal-title":"Nephrol Dial Transplant"},{"issue":"7","key":"1208_CR84","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1093\/ndt\/gfu237","volume":"30","author":"A Tanna","year":"2015","unstructured":"Tanna A, Guarino L, Tam FW, Rodriquez-Cubillo B, Levy JB, Cairns TD, et al. Long-term outcome of anti-neutrophil cytoplasm antibody-associated glomerulonephritis: evaluation of the international histological classification and other prognostic factors. Nephrol Dial Transplant. 2015;30(7):1185\u201392. https:\/\/doi.org\/10.1093\/ndt\/gfu237.","journal-title":"Nephrol Dial Transplant"},{"issue":"10","key":"1208_CR85","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1681\/ASN.2010050477","volume":"21","author":"AE Berden","year":"2010","unstructured":"Berden AE, Ferrario F, Hagen EC, Jayne DR, Jennette JC, Joh K, et al. Histopathologic classification of ANCA-associated glomerulonephritis. J Am Soc Nephrol. 2010;21(10):1628\u201336. https:\/\/doi.org\/10.1681\/ASN.2010050477.","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"1208_CR86","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1681\/ASN.2012090912","volume":"24","author":"M Hilhorst","year":"2013","unstructured":"Hilhorst M, Wilde B, van Breda Vriesman P, van Paassen P, Cohen Tervaert JW, Limburg Renal Registry. Estimating renal survival using the ANCA-associated GN classification. J Am Soc Nephrol. 2013;24(9):1371\u20135. https:\/\/doi.org\/10.1681\/ASN.2012090912.","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"1208_CR87","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1007\/s10067-016-3195-z","volume":"35","author":"BM C\u00f3rdova-S\u00e1nchez","year":"2016","unstructured":"C\u00f3rdova-S\u00e1nchez BM, Mej\u00eda-Vilet JM, Morales-Buenrostro LE, Loyola-Rodr\u00edguez G, Uribe-Uribe NO, Correa-Rotter R. Clinical presentation and outcome prediction of clinical, serological, and histopathological classification schemes in ANCA-associated vasculitis with renal involvement. Clin Rheumatol. 2016;35(7):1805\u201316. https:\/\/doi.org\/10.1007\/s10067-016-3195-z.","journal-title":"Clin Rheumatol"},{"issue":"2","key":"1208_CR88","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1093\/ndt\/gfy220","volume":"34","author":"S Sethi","year":"2019","unstructured":"Sethi S, Fervenza FC. Standardized classification and reporting of glomerulonephritis. Nephrol Dial Transplant. 2019;34(2):193\u20139. https:\/\/doi.org\/10.1093\/ndt\/gfy220.","journal-title":"Nephrol Dial Transplant"},{"issue":"9","key":"1208_CR89","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1093\/ndt\/gfab250","volume":"37","author":"M Casal Moura","year":"2022","unstructured":"Casal Moura M, Fervenza FC, Specks U, Sethi S. Kidney biopsy chronicity grading in antineutrophil cytoplasmic antibody-associated vasculitis. Nephrol Dial Transplant. 2022;37(9):1710\u201321. https:\/\/doi.org\/10.1093\/ndt\/gfab250.","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"1208_CR90","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.ekir.2024.01.007","volume":"9","author":"R Takeda","year":"2024","unstructured":"Takeda R, Takahashi K, Kronbichler A, Akiyama D, Hanai S, Kobayashi Y, et al. Development of a kidney prognostic score in a Japanese cohort of patients with antineutrophil cytoplasmic autoantibody vasculitis. Kidney Int Rep. 2024;9(3):611\u201323. https:\/\/doi.org\/10.1016\/j.ekir.2024.01.007.","journal-title":"Kidney Int Rep"},{"key":"1208_CR91","doi-asserted-by":"crossref","unstructured":"91. Brix SR, Noriega M, Tennstedt P, Vettorazzi E, Busch M, Nitschke M, et al. Development and validation of a renal risk score in ANCA-associated glomerulonephritis. Kidney Int. 2018;94(6):1177-88. 10.1016\/j.kint.2018.07.020.","DOI":"10.1016\/j.kint.2018.07.020"},{"key":"1208_CR92","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.736754","volume":"8","author":"M Xia","year":"2022","unstructured":"Xia M, Yu R, Zheng Z, Li H, Feng J, Xie X, et al. Meta-analytical accuracy of ANCA renal risk score for prediction of renal outcome in patients with ANCA-associated glomerulonephritis. Front Med. 2022;8:736754. https:\/\/doi.org\/10.3389\/fmed.2021.736754.","journal-title":"Front Med"},{"issue":"3","key":"1208_CR93","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1681\/ASN.0000000000000274","volume":"35","author":"S Bate","year":"2024","unstructured":"Bate S, McGovern D, Costigliolo F, Tan PG, Kratky V, Scott J, et al. The improved kidney risk score in ANCA-associated vasculitis for clinical practice and trials. J Am Soc Nephrol. 2024;35(3):335\u201346. https:\/\/doi.org\/10.1681\/ASN.0000000000000274.","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"1208_CR94","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1093\/rheumatology\/keae336","volume":"64","author":"MJ Sandino-Berm\u00fadez","year":"2025","unstructured":"Sandino-Berm\u00fadez MJ, Hern\u00e1ndez-Andrade A, Hinojosa-Azaola A, Mart\u00edn-Nares E, Mej\u00eda-Vilet JM. Performance of clinical and histological prognostic scores for kidney survival in ANCA-associated vasculitis. Rheumatology (Oxford). 2025;64(4):1981\u20138. https:\/\/doi.org\/10.1093\/rheumatology\/keae336.","journal-title":"Rheumatology (Oxford)"},{"issue":"12","key":"1208_CR95","doi-asserted-by":"publisher","first-page":"2530","DOI":"10.1093\/ckj\/sfad157","volume":"16","author":"C Boud'hors","year":"2023","unstructured":"Boud\u2019hors C, Riou J, Fage N, Samoreau C, Desouche A, Gatault P, et al. Adding 6-month parameters for the prediction of kidney prognosis in ANCA-associated glomerulonephritis. Clin Kidney J. 2023;16(12):2530\u201341. https:\/\/doi.org\/10.1093\/ckj\/sfad157.","journal-title":"Clin Kidney J"},{"issue":"4","key":"1208_CR96","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1007\/s40620-023-01855-x","volume":"37","author":"M Christodoulou","year":"2024","unstructured":"Christodoulou M, Moysidou E, Lioulios G, Stai S, Bandis K, Flaris N, et al. The prognostic value of two histopathologic classification models of ANCA-associated glomerulonephritis: a prospective study. J Nephrol. 2024;37(4):941\u201350. https:\/\/doi.org\/10.1007\/s40620-023-01855-x.","journal-title":"J Nephrol"},{"issue":"12","key":"1208_CR97","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1136\/ard.2008.101279","volume":"68","author":"C Mukhtyar","year":"2009","unstructured":"Mukhtyar C, Lee R, Brown D, Carruthers D, Dasgupta B, Dubey S, et al. Modification and validation of the Birmingham Vasculitis Activity Score (version 3). Ann Rheum Dis. 2009;68(12):1827\u201332. https:\/\/doi.org\/10.1136\/ard.2008.101279.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"1208_CR98","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-024-00589-9","volume":"11","author":"P Romagnani","year":"2025","unstructured":"Romagnani P, Agarwal R, Chan JCN, Levin A, Kalyesubula R, Karam S, et al. Chronic kidney disease. Nat Rev Dis Primers. 2025;11(1):8. https:\/\/doi.org\/10.1038\/s41572-024-00589-9.","journal-title":"Nat Rev Dis Primers"},{"key":"1208_CR99","doi-asserted-by":"crossref","unstructured":"99. Khan MS, Shahid I, Anker SD, Fonarow GC, Fudim M, Hall ME, et al. Albuminuria and Heart failure: JACC state-of-art review. J Am Coll Cardiol. 2023;81(3):270\u2009\u2212\u200982. 10.1016\/j.jacc.2022.10.028.","DOI":"10.1016\/j.jacc.2022.10.028"},{"issue":"7","key":"1208_CR100","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1056\/NEJMoa2023386","volume":"384","author":"DRW Jayne","year":"2021","unstructured":"Jayne DRW, Merkel PA, Schall TJ, Bekker P. Avacopan for the treatment of ANCA-associated vasculitis. N Engl J Med. 2021;384(7):599\u2013609. https:\/\/doi.org\/10.1056\/NEJMoa2023386.","journal-title":"N Engl J Med"},{"issue":"6","key":"1208_CR101","doi-asserted-by":"publisher","first-page":"426","DOI":"10.7326\/M20-0529","volume":"173","author":"K Sumida","year":"2020","unstructured":"Sumida K, Nadkarni GN, Grams ME, Sang Y, Ballew SH, Coresh J, et al. Conversion of urine protein-creatinine ratio urine dipstick protein to urine albumin-creatinine ratio for use in chronic kidney disease screening and prognosis: An individual participant-based meta-analysis. Ann Intern Med. 2020;173(6):426\u201335. https:\/\/doi.org\/10.7326\/M20-0529.","journal-title":"Ann Intern Med."},{"issue":"6","key":"1208_CR102","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1016\/j.kint.2023.02.029","volume":"103","author":"N Benichou","year":"2023","unstructured":"Benichou N, Charles P, Terrier B, Jones RB, Hiemstra T, Mouthon L, et al. Proteinuria and hematuria after remission induction are associated with outcome in ANCA-associated vasculitis. Kidney Int. 2023;103(6):1144\u201355. https:\/\/doi.org\/10.1016\/j.kint.2023.02.029.","journal-title":"Kidney Int"},{"issue":"5","key":"1208_CR103","doi-asserted-by":"publisher","first-page":"e34","DOI":"10.1097\/RHU.0000000000002227","volume":"31","author":"A Hernandez-Andrade","year":"2025","unstructured":"Hernandez-Andrade A, Zavala-Miranda MF, Hinojosa-Azaola A, Navarro-S\u00e1nchez V, Nordmann-Gomes A, Rivero-Otamendi E, et al. Outcomes in Mexican patients with antineutrophil cytoplasmic antibody-associated vasculitis with kidney involvement. J Clin Rheumatol. 2025;31(5):e34\u201341. https:\/\/doi.org\/10.1097\/RHU.0000000000002227.","journal-title":"J Clin Rheumatol"},{"issue":"2","key":"1208_CR104","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1093\/ndt\/gfz082","volume":"35","author":"FWK Tam","year":"2020","unstructured":"Tam FWK, Ong ACM. Renal monocyte chemoattractant protein-1: an emerging universal biomarker and therapeutic target for kidney diseases? Nephrol Dial Transplant. 2020;35(2):198\u2013203. https:\/\/doi.org\/10.1093\/ndt\/gfz082.","journal-title":"Nephrol Dial Transplant"},{"key":"1208_CR105","doi-asserted-by":"publisher","first-page":"2761","DOI":"10.1093\/ndt\/gfh487","volume":"19","author":"FWK Tam","year":"2004","unstructured":"Tam FWK, Sanders JS, George A, Hammad T, Miller C, Dougan T, et al. Urinary monocyte chemoattractant protein-1 (MCP-1) is a marker of active renal vasculitis. Nephrol Dial Transplant. 2004;19:2761\u20138. https:\/\/doi.org\/10.1093\/ndt\/gfh487.","journal-title":"Nephrol Dial Transplant."},{"issue":"6","key":"1208_CR106","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1093\/ndt\/gfv336","volume":"31","author":"A Kronbichler","year":"2016","unstructured":"Kronbichler A, Kerschbaum J, Gr\u00fcndlinger G, Leierer J, Mayer G, Rudnicki M. Evaluation and validation of biomarkers in granulomatosis with polyangiitis and microscopic polyangiitis. Nephrol Dial Transplant. 2016;31(6):930\u20136. https:\/\/doi.org\/10.1093\/ndt\/gfv336.","journal-title":"Nephrol Dial Transplant"},{"issue":"9","key":"1208_CR107","doi-asserted-by":"publisher","first-page":"2906","DOI":"10.1681\/ASN.2015050511","volume":"27","author":"VP O\u2019Reilly","year":"2016","unstructured":"O\u2019Reilly VP, Wong L, Kennedy C, Elliot LA, O\u2019Meachair S, Coughlan AM, et al. Urinary soluble CD163 in active renal vasculitis. J Am Soc Nephrol. 2016;27(9):2906\u201316. https:\/\/doi.org\/10.1681\/ASN.2015050511.","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"1208_CR108","doi-asserted-by":"publisher","first-page":"2920","DOI":"10.1681\/ASN.2021030382","volume":"32","author":"SM Moran","year":"2021","unstructured":"Moran SM, Scott J, Clarkson MR, Conlon N, Dunne J, Griffin MD, et al. The clinical application of urine soluble CD163 in ANCA-associated vasculitis. J Am Soc Nephrol. 2021;32(11):2920\u201332. https:\/\/doi.org\/10.1681\/ASN.2021030382.","journal-title":"J Am Soc Nephrol"},{"key":"1208_CR109","doi-asserted-by":"crossref","unstructured":"109. Moran SM, Monach PA, Zgaga L, Cuthbertson D, Carette S, Khalidi NA, et al. Urinary soluble CD163 and monocyte chemoattractant protein-1 in the identification of subtle renal flare in anti-neutrophil cytoplasmic antibody-associated vasculitis. Nephrol Dial Transplant. 2020;35(2):283\u221291. 10.1093\/ndt\/gfy300.","DOI":"10.1093\/ndt\/gfy300"},{"key":"1208_CR110","doi-asserted-by":"crossref","unstructured":"110. Dekkema GJ, Abdulahad WH, Bijma T, Moran SM, Ryan L, Little MA, et al. Urinary and serum soluble CD25 complements urinary soluble CD163 active renal anti-neutrophil cytoplasmic autoantibody-associated vasculitis cohort study. Nephrol Dial Transplant. 2019;34(2):234\u221242. 10.1093\/ndt\/gfy018.","DOI":"10.1093\/ndt\/gfy018"},{"issue":"4","key":"1208_CR111","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1093\/ckj\/sfac257","volume":"16","author":"P Anton-Pampols","year":"2022","unstructured":"Anton-Pampols P, Valenzuela LM, Fern\u00e1ndez-Lorente L, Quero-Ramos M, G\u00f3mez-Preciado F, Mart\u00edn- Cap\u00f3n I, et al. Combining neutrophil and macrophage biomarkers to detect active disease in ANCA vasculitis: a combinatory model of calprotectin and urine CD163. Clin Kidney J. 2022;16(4):693\u2013700. https:\/\/doi.org\/10.1093\/ckj\/sfac257.","journal-title":"Clin Kidney J."},{"issue":"3","key":"1208_CR112","doi-asserted-by":"publisher","first-page":"586","DOI":"10.34067\/KID.0006432020","volume":"2","author":"AD Morris","year":"2021","unstructured":"Morris AD, Rowbottom AW, Martin FL, Woywodt A, Dhaygude AP. Biomarkers in ANCA-associated vasculitis: potential pitfalls and future prospects. Kidney360. 2021;2(3):586\u201397. https:\/\/doi.org\/10.34067\/KID.0006432020.","journal-title":"Kidney360"},{"issue":"11","key":"1208_CR113","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.2215\/CJN.02790313","volume":"8","author":"SJ Gou","year":"2013","unstructured":"Gou SJ, Yuan J, Wang C, Zhao MH, Chen M. Alternative complement pathway activation products in urine and kidneys of patients with ANCA-associated GN. Clin J Am Soc Nephrol. 2013;8(11):1884\u201391. https:\/\/doi.org\/10.2215\/CJN.02790313.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"1208_CR114","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/ki.2012.313","volume":"83","author":"SJ Gou","year":"2023","unstructured":"Gou SJ, Yuan J, Yu F, Zhao MH. Circulating complement activation in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis. Kidney Int. 2023;83(1):129\u201337. https:\/\/doi.org\/10.1038\/ki.2012.313.","journal-title":"Kidney Int"},{"issue":"11","key":"1208_CR115","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.1016\/j.ekir.2023.08.017","volume":"8","author":"S Almaani","year":"2023","unstructured":"Almaani S, Song H, Suthanthira M, Toy C, Fussner LA, Meara A, et al. Urine and plasma complement Ba levels during disease flares in patients with antineutrophil cytoplasmic autoantibody-associated vasculitis. Kidney Int Rep. 2023;8(11):2421\u20137. https:\/\/doi.org\/10.1016\/j.ekir.2023.08.017.","journal-title":"Kidney Int Rep"},{"issue":"4","key":"1208_CR116","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.ekir.2023.01.013","volume":"8","author":"J Sonnemann","year":"2023","unstructured":"Sonnemann J, Klocke J, Bieringer M, Rousselle A, Eckardt KU, Elitok S, et al. Urinary T cells identify renal antineutrophil cytoplasmic antibody-associated vasculitis and predict prognosis: a proof of concept study. Kidney Int Rep. 2023;8(4):871\u201383. https:\/\/doi.org\/10.1016\/j.ekir.2023.01.013.","journal-title":"Kidney Int Rep"},{"key":"1208_CR117","doi-asserted-by":"publisher","DOI":"10.1038\/srep38074","volume":"6","author":"B Al-Ani","year":"2016","unstructured":"Al-Ani B, Fitzpatrick M, Al-Nuaimi H, Coughlan AM, Hickey FB, Pusey CD, et al. Changes in urinary metabolomic profile during relapsing renal vasculitis. Sci Rep. 2016;6:38074. https:\/\/doi.org\/10.1038\/srep38074.","journal-title":"Sci Rep"},{"issue":"6","key":"1208_CR118","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1681\/ASN.0000000705","volume":"36","author":"SB Beckmann","year":"2025","unstructured":"Beckmann SB, Salib M, Fenton RA, Hoorn EJ. Toward assessment of tubular function in kidney disease. J Am Soc Nephrol. 2025;36(6):1201\u20133. https:\/\/doi.org\/10.1681\/ASN.0000000705.","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"1208_CR119","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0224690","volume":"14","author":"S Tachibana","year":"2019","unstructured":"Tachibana S, Iyoda M, Suzuki T, Kanazawa N, Iseri K, Wada Y, et al. Serum uromodulin is associated with the severity of clinicopathological findings in ANCA-associated glomerulonephritis. PLoS One. 2019;14(11):e0224690. https:\/\/doi.org\/10.1371\/journal.pone.0224690.","journal-title":"PLoS One"},{"issue":"9","key":"1208_CR120","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1136\/annrheumdis-2017-212578","volume":"77","author":"L Wu","year":"2018","unstructured":"Wu L, Li XQ, Goyal T, Eddy S, Kretzler M, Ju WJ, et al. Urinary epidermal growth factor predicts renal prognosis in antineutrophil cytoplasmic antibody-associated vasculitis. Ann Rheum Dis. 2018;77(9):1339\u201344. https:\/\/doi.org\/10.1136\/annrheumdis-2017-212578.","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"1208_CR121","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1007\/s40620-024-02068-6","volume":"37","author":"A Hern\u00e1ndez-Andrade","year":"2024","unstructured":"Hern\u00e1ndez-Andrade A, Nordmann-Gomes A, Ju\u00e1rez-Cuevas A, Zavala-Miranda MF, Cruz C, Mejia-Vilet JM. Urine epidermal growth factor as a biomarker for kidney function recovery and prognosis in glomerulonephritis with severe kidney function impairment. J Nephrol. 2024;37(8):2243\u201353. https:\/\/doi.org\/10.1007\/s40620-024-02068-6.","journal-title":"J Nephrol"},{"key":"1208_CR122","doi-asserted-by":"crossref","unstructured":"122. Brilland B, Boud\u2019hors C, Wacrenier S, Blanchard S, Cayon J, Blanchet O, et al. Kidney injury molecule 1 (KIM-1): a potential biomarker of acute kidney injury and tubulointerstitial injury in patients with ANCA glomerulonephritis. Clin Kidney J. 2023;16(9):1521-33. 10.1093\/ckj\/sfad071.","DOI":"10.1093\/ckj\/sfad071"},{"issue":"11","key":"1208_CR123","doi-asserted-by":"publisher","first-page":"2722","DOI":"10.1681\/ASN.2018040405","volume":"29","author":"S Zewinger","year":"2018","unstructured":"Zewinger S, Rauen T, Rudnicki M, Federico G, Wagner M, Triem S, et al. Dickkopf-3 (DKK3) in urine identifies patients with short-term risk of eGFR loss. J Am Soc Nephrol. 2018;29(11):2722\u201333. https:\/\/doi.org\/10.1681\/ASN.2018040405.","journal-title":"J Am Soc Nephrol"},{"key":"1208_CR124","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1122972","volume":"14","author":"V Satrapova","year":"2023","unstructured":"Satrapova V, Sparding N, Genovese F, Karsdal MA, Bartonova l, Frausova D, et al. Biomarkers of fibrosis, kidney tissue injury and inflammation may predict severity and outcomes of renal ANCA-associated vasculitis. Front Immunol. 2023;14:1122972. https:\/\/doi.org\/10.3389\/fimmu.2023.1122972.","journal-title":"Front Immunol"}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-025-01208-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11926-025-01208-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-025-01208-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T10:53:04Z","timestamp":1768474384000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11926-025-01208-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,12]]},"references-count":124,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1208"],"URL":"https:\/\/doi.org\/10.1007\/s11926-025-01208-6","relation":{},"ISSN":["1534-6307"],"issn-type":[{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,12]]},"assertion":[{"value":"15 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1"}}